EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C18H19F3N2S |
| Net Charge | 0 |
| Average Mass | 352.425 |
| Monoisotopic Mass | 352.12210 |
| SMILES | CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 |
| InChI | InChI=1S/C18H19F3N2S/c1-22(2)10-5-11-23-14-6-3-4-7-16(14)24-17-9-8-13(12-15(17)23)18(19,20)21/h3-4,6-9,12H,5,10-11H2,1-2H3 |
| InChIKey | XSCGXQMFQXDFCW-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | anticoronaviral agent Any antiviral agent which inhibits the activity of coronaviruses. dopaminergic antagonist A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists. |
| Applications: | antiemetic A drug used to prevent nausea or vomiting. An antiemetic may act by a wide range of mechanisms: it might affect the medullary control centres (the vomiting centre and the chemoreceptive trigger zone) or affect the peripheral receptors. first generation antipsychotic Antipsychotic drugs which can have different modes of action but which tend to be more likely than second generation antipsychotics to cause extrapyramidal motor control disabilities such as body rigidity or Parkinson's disease-type movements; such body movements can become permanent even after treatment has ceased. dopaminergic antagonist A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| triflupromazine (CHEBI:9711) has parent hydride 10H-phenothiazine (CHEBI:37931) |
| triflupromazine (CHEBI:9711) has role anticoronaviral agent (CHEBI:149553) |
| triflupromazine (CHEBI:9711) has role antiemetic (CHEBI:50919) |
| triflupromazine (CHEBI:9711) has role dopaminergic antagonist (CHEBI:48561) |
| triflupromazine (CHEBI:9711) has role first generation antipsychotic (CHEBI:65190) |
| triflupromazine (CHEBI:9711) is a organofluorine compound (CHEBI:37143) |
| triflupromazine (CHEBI:9711) is a phenothiazines (CHEBI:38093) |
| triflupromazine (CHEBI:9711) is a tertiary amine (CHEBI:32876) |
| Incoming Relation(s) |
| triflupromazine hydrochloride (CHEBI:9712) has part triflupromazine (CHEBI:9711) |
| IUPAC Name |
|---|
| N,N-dimethyl-3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propan-1-amine |
| INNs | Source |
|---|---|
| triflupromazine | ChEBI |
| triflupromazina | ChEBI |
| triflupromazinum | ChEBI |
| Synonyms | Source |
|---|---|
| 10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine | ChemIDplus |
| 2-(Trifluoromethyl)promazine | ChemIDplus |
| 2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine | ChemIDplus |
| trifluopromazine | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| D00390 | KEGG DRUG |
| DB00508 | DrugBank |
| GB813861 | Patent |
| Triflupromazine | Wikipedia |
| HMDB0014650 | HMDB |
| LSM-3421 | LINCS |
| 2742 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| Reaxys:335308 | Reaxys |
| CAS:146-54-3 | ChemIDplus |
| Citations |
|---|